Literature DB >> 2989650

Benzodiazepine receptor binding in vivo with [3H]-Ro 15-1788.

N E Goeders, M J Kuhar.   

Abstract

In vivo benzodiazepine receptor binding has generally been studied by "ex vivo" techniques. In this investigation, we identify the conditions where [3H]-Ro 15-1788 labels benzodiazepine receptors by true "in vivo" binding, i.e. where workable specific to nonspecific ratios are obtained in intact tissues without homogenization or washing. [3H]-Flunitrazepam and [3H]-clonazepam did not exhibit useful in vivo receptor binding.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989650     DOI: 10.1016/0024-3205(85)90505-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats.

Authors:  Anne B Need; Richard J Davis; Jesline T Alexander-Chacko; Brian Eastwood; Eyassu Chernet; Lee A Phebus; Dana K Sindelar; George G Nomikos
Journal:  Psychopharmacology (Berl)       Date:  2005-11-18       Impact factor: 4.530

2.  Acute barbiturate administration increases benzodiazepine receptor binding in vivo.

Authors:  L G Miller; S I Deutsch; D J Greenblatt; S M Paul; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  A quantitative cerebral and whole body autoradiographic study of a intravenously administered benzodiazepine antagonist 3H-Ro 15-1788 in mice.

Authors:  R d'Argy; A Persson; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Early-stage 11C-Flumazenil PET predicts day-14 selective neuronal loss in a rodent model of transient focal cerebral ischemia.

Authors:  Jessica L Hughes; John S Beech; P Simon Jones; Dechao Wang; David K Menon; Franklin I Aigbirhio; Tim D Fryer; Jean-Claude Baron
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-22       Impact factor: 6.200

5.  Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero.

Authors:  J R Martin; P Schoch; F Jenck; J L Moreau; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system.

Authors:  D J Sanger; J Benavides
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, alpha5IA, is similar in rats and primates.

Authors:  John R Atack; Wai-Si Eng; Ray E Gibson; Christine Ryan; Barbara Francis; Bindi Sohal; Gerard R Dawson; Richard J Hargreaves; H Donald Burns
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

8.  Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.

Authors:  A K Larsen; L T Brennum; J Egebjerg; C Sánchez; C Halldin; P H Andersen
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

9.  Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.

Authors:  R E See; A W Toga; G Ellison
Journal:  J Neural Transm Gen Sect       Date:  1990
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.